Clinical trial
CTI-01 (Ethyl Pyruvate) Safety and Complication Prevention in Cardiac Surgery…
NCT00107666 · Critical Therapeutics, Industry · Terminated
Key facts
| NCT number | NCT00107666 |
|---|---|
| Title | CTI-01 (Ethyl Pyruvate) Safety and Complication Prevention in Cardiac Surgery Patients on Cardiopulmonary Bypass (CPB) |
| Official title | A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter, Proof of Concept Clinical Study of CTI-01 in Patients Undergoing Major Cardiac Surgery With Cardiopulmonary Bypass |
| Lead sponsor | Critical Therapeutics, Industry |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Coronary Disease, Heart Valve Diseases |
| Intervention type | Drug |
| Interventions | CTI-01 (ethyl pyruvate) |
| Enrollment | 150 |
| Start date | Apr 1, 2005 |
| Completion | Apr 1, 2006 |
| First posted | Apr 7, 2005 |
| Last update posted | Mar 17, 2006 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: